Trial Profile
Skin Residency Study of Topically Applied GSK2894512 Cream in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs GSK 2894512 (Primary)
- Indications Atopic dermatitis
- Focus Pharmacokinetics
- Sponsors Stiefel Laboratories
- 10 Nov 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 22 Sep 2015 Planned End Date changed from 1 Aug 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov record.
- 22 Sep 2015 Planned primary completion date changed from 1 Aug 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov record.